The SWEET consortium was pleased to present an invited symposium at Zoom Forward 22, the 29th annual European Congress on Obesity held in Maastricht and online. Congress registration exceeded 2000 delegates. The SWEET project looks at alternate sweeteners and sweetness enhancers, engaging stakeholders across the food chain, including health professionals, patients, scientists and policymakers, to assess the role of sweeteners in weight control.

On 7 May 2022 several Consortium members joined the live symposium. The Principal Investigator presented a comprehensive overview of the project and description of the long term clinical trial; colleagues also led delegates through a presentation around  processes of developing lower-sugar foods using Sweeteners and Sweetness Enhancers (S&SEs) for use in Human Clinical Trials and understanding health impacts; presentation  of results from the SWEET beverages trial; analysis from the Gemini (twins) cohort and the UK National Diet and Nutrition Survey around intake of free-sugars and guideline adherence; preliminary perspectives on the Life Cycle Sustainability Assessment (LCSA) of sweeteners; and risk and benefit communication and perceptions around S&SEs in UK and Spanish media. An engaging panel discussion followed.

PI Anne Raben said “ The Consortium was delighted to have the opportunity to present an in-person SWEET project Symposium at a prominent annual congress after a 2 year hiatus due to COVID-19. In spite of the pandemic, the team has made substantial progress in moving the project forward in all included work packages.”

The live symposium remains available to view on replay to those registered on the platform at:

If you are involved in the field and interested in learning more about the project, you are welcome you to join the conversation. Learn more and share your views, join a stakeholder session:

Contact: [email protected]

Symposium presentation titles appear below.


A SWEET start. Project overview and status on the long-term clinical trial A Raben (Denmark)
11:40 – 11:50 Development of Sugar Reduced Foods using Sweeteners and Sweetness Enhancers for use in Human Clinical Trials and Accompanying Health Impact and Technological Databases – the SWEET project. C Scott (Belgium)
11:50 – 12:00 Impact on food intake, metabolism and gastro-intestinal symptoms after acute consumption of beverages containing plant-based or alternative sweeteners. Results of the SWEET Beverages trial. EA Roig (Spain)
12:00 – 12:10 Free sugar intake and guideline adherence by British children from the Gemini cohort and the National Diet and Nutrition Survey: the SWEET project L Heggie (UK)
12:10 – 12:20 “SWEET sustainability” – early insights on the Life Cycle Sustainability Assessment (LCSA) of sweeteners M Raats (UK)
12:20 – 12:30 Identification of risk and benefit communication of sweeteners and sweetness enhancers (S&SEs) in the UK and Spanish media – the SWEET project M Raats (UK)
12:30 – 13:00 Panel Discussion All